Tobias Haltmeier

Organ-sparing therapy with definitive radio-chemotherapy (RCT) for esophageal cancer (EC) is gaining clinical importance. However, there is scarce data on the optimal follow-up strategy of such a watch&wait approach…

The current standard of care for the treatment of esophageal cancer (EC) in a curative intent consists of neoadjuvant radiochemotherapy (RCT) followed by resection…